Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

Health and Healthcare

Merck : MRK

All Merck Articles

1079 Articles

Chris Lange | Apr 13, 2020 at 9:58 AM EDT

Big Pharma Short Sellers Focus on a Couple of Favorites

The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Jon C. Ogg | Mar 16, 2020 at 1:32 PM EDT

9 Dividends That Should Absolutely Not Be Killed During the Coronavirus Recession

24/7 Wall St. wanted to see which companies have the best chance at not having to lower their dividends at…

Chris Lange | Mar 11, 2020 at 9:44 AM EDT

Short Sellers Run for Cover From Big Pharma Stocks

The February 28 short interest data have been compared with the previous figures, and short interest in these top pharmaceutical…

Chris Lange | Feb 27, 2020 at 8:45 AM EST

Big Pharma Scares Off Short Sellers

The February 14 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 20, 2020 at 7:35 AM EST

15 Top ESG Stocks That Look Undervalued for 2020

With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks…

Chris Lange | Feb 12, 2020 at 9:50 AM EST

Big Pharma Sees a Rising Tide in Short Interest

The January 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Feb 6, 2020 at 8:45 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive,…

Jon C. Ogg | Feb 5, 2020 at 1:20 PM EST

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Merck finds itself in a position of being an acquirer of sorts at the same time it wants to spin…

Chris Lange | Feb 5, 2020 at 9:55 AM EST

Is Merck Stuck in the Slow Lane?

Merck reported fourth-quarter financial results before the markets opened on Wednesday that were essentially in line with expectations, yet shares…

Chris Lange | Feb 4, 2020 at 1:05 PM EST

What to Expect When Merck Reports Before the Opening Bell

Merck is scheduled to release its fourth-quarter financial results before the markets open on Wednesday. Analysts are looking for year-over-year…

Chris Lange | Feb 2, 2020 at 7:05 AM EST

Alphabet, Disney, Ford, Twitter, Uber and More Major Earnings Coming This Week

24/7 Wall St. has put together a preview of Disney, Ford, Merck, Uber and some of the other most anticipated…

Chris Lange | Jan 28, 2020 at 9:35 AM EST

Short Sellers Can’t Make Up Their Mind on Big Pharma

The January 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jan 13, 2020 at 9:40 AM EST

Short Sellers Shy Away From Big Pharma

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 6, 2020 at 12:45 PM EST

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Here is a review and preview of how the model for Dow Jones industrial average could point to a baseline…

Jon C. Ogg | Jan 2, 2020 at 4:51 PM EST

Is Pfizer Raising Drug Prices Too Much in 2020?

Ahead of election years, the cost and future of health care has become one of the top debates for better…

1 … 12 13 14 15 16 … 72

Merck : MRK

All Merck Articles

Big Pharma Short Sellers Focus on a Couple of Favorites

9 Dividends That Should Absolutely Not Be Killed During the Coronavirus Recession

Short Sellers Run for Cover From Big Pharma Stocks

Big Pharma Scares Off Short Sellers

15 Top ESG Stocks That Look Undervalued for 2020

Big Pharma Sees a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Is Merck Stuck in the Slow Lane?

What to Expect When Merck Reports Before the Opening Bell

Alphabet, Disney, Ford, Twitter, Uber and More Major Earnings Coming This Week

Short Sellers Can’t Make Up Their Mind on Big Pharma

Short Sellers Shy Away From Big Pharma

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

New Inflation Data Confirms the end of Kevin Warsh’s Honeymoon

Fidelity’s 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

Hedge Fund Investor Says Today’s AI Boom Is ‘Nothing’ Compared to 1999 Dot-Com Bubble

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill

New Inflation Data Confirms the end of Kevin Warsh’s Honeymoon

Fidelity’s 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

Merck : MRK

All Merck Articles

Big Pharma Short Sellers Focus on a Couple of Favorites

9 Dividends That Should Absolutely Not Be Killed During the Coronavirus Recession

Short Sellers Run for Cover From Big Pharma Stocks

Big Pharma Scares Off Short Sellers

15 Top ESG Stocks That Look Undervalued for 2020

Big Pharma Sees a Rising Tide in Short Interest

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More

Merck’s Spin-Off May Create Operational Risks for the Year Ahead

Is Merck Stuck in the Slow Lane?

What to Expect When Merck Reports Before the Opening Bell

Alphabet, Disney, Ford, Twitter, Uber and More Major Earnings Coming This Week

Short Sellers Can’t Make Up Their Mind on Big Pharma

Short Sellers Shy Away From Big Pharma

2020 Bull/Bear Outlook Sees the Dow Rising to 30,650 Before Year-End

Is Pfizer Raising Drug Prices Too Much in 2020?

Live: Will Casey’s Crush Q4 Earnings Tonight After The Bell?

New Inflation Data Confirms the end of Kevin Warsh’s Honeymoon

Fidelity’s 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

Hedge Fund Investor Says Today’s AI Boom Is ‘Nothing’ Compared to 1999 Dot-Com Bubble

Featured Reads

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

74-Year-Old With $2.6M Discovers Late Husband's IRA RMD Doubled Her Tax Bill